한글목차

뇌영상 시장은 2025년 422억 8,000만 달러, 2032년에는 635억 7,000만 달러에 이를 것으로 예측되며, 2025-2032년 CAGR 6%를 보일 것으로 예측됩니다.

뇌영상은 뇌의 구조와 기능을 시각화하는 의료영상 분야의 한 분야입니다. 다양한 질병과 장애의 기저에 있는 신경학적 과정과 이상에 대한 귀중한 통찰력을 제공합니다. 이 기술은 신경과학 분야에 혁명을 가져왔으며, 인간의 뇌를 이해하는 데 크게 기여하고 있습니다.

시장 역학:

뇌영상 시장은 몇 가지 요인에 의해 주도되고 있습니다. 신경 질환의 유병률 증가는 정확한 진단 도구에 대한 수요를 증가시켜 뇌영상 기술의 채택으로 이어지고 있습니다. 또한, 자기공명영상(MRI), 양전자방사선단층촬영(PET), 컴퓨터단층촬영(CT) 등 영상 기술의 발전으로 뇌 영상의 해상도와 정확도가 크게 향상되고 있습니다.

그러나 시장에는 일정한 억제요인도 있습니다. 특히 개발도상국에서는 뇌영상 진단 장비의 높은 비용과 그에 따른 유지보수 및 운영 비용으로 인해 접근성이 제한되고 있으며, CT 스캔에서 발생하는 전리 방사선 노출과 같은 특정 영상 촬영의 안전성에 대한 우려는 시장 성장의 걸림돌로 작용하고 있습니다.

그럼에도 불구하고, 뇌영상 시장에는 몇 가지 비즈니스 기회가 있습니다. 기능적 자기공명영상(fMRI), 확산텐서영상(DTI)과 같은 첨단 영상 기술 개발을 위한 연구개발(R&D) 활동에 대한 투자가 증가하고 있으며, 이는 시장 성장의 원동력이 될 것으로 예측됩니다. 개인 맞춤형 의료에 대한 관심 증가와 뇌영상에 인공지능(AI)의 통합은 시장 확대의 새로운 길을 제공할 것입니다.

본 조사의 주요 특징

• 이 보고서는 뇌영상 시장을 상세하게 분석하여 2024년을 기준 연도로 하여 2025-2032년까지의 예측 기간 동안 시장 규모와 연평균 성장률(CAGR)을 예측한 보고서입니다.
• 또한, 다양한 부문의 잠재적 수익 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
• 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략 등에 대한 주요 고찰을 제공합니다.
• 이 보고서는 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 성과, 전략 등의 매개 변수를 기반으로 뇌영상 시장의 주요 기업을 프로파일링합니다.
• 이 보고서의 통찰력을 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형화, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
• 뇌영상 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 다양한 이해관계자를 대상으로 합니다.
• 이해관계자들은 뇌영상 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있습니다.

목차

제1장 조사 목적과 전제조건

• 조사 목적
• 전제조건
• 약어

제2장 시장 전망

• 보고서 설명
  • 시장 정의와 범위
• 주요 요약
• Coherent Opportunity Map(COM)

제3장 시장 역학, 규제, 동향 분석

• 시장 역학
• 시장 성장 억제요인
• 시장 기회
• 주요 하이라이트
• 규제 시나리오
• 최근 동향
• 제품 발매 및 승인
• PEST 분석
• PORTER 분석
• 합병, 인수 및 제휴

제4장 뇌영상 시장 - 코로나바이러스(COVID-19) 팬데믹의 영향

• COVID-19 역학
• 공급측과 수요측 분석
• 경제에 대한 영향

제5장 뇌영상 시장, 기술별, 2020년-2032년

• 자기공명영상(MRI)
• 컴퓨터 단층촬영(CT)
• 양전자 방출 단층촬영(PET)
• 단일 광자 방출 컴퓨터 단층촬영(SPECT)
• 기능적 자기공명영상(fMRI)
• 확산 텐서 영상(DTI)
• 뇌자도(MEG)
• 뇌파검사(EEG)
• 기타

제6장 뇌영상 시장, 용도별, 2020년-2032년

• 신경질환
• 알츠하이머병
• 파킨슨병
• 다발성 경화증
• 간질
• 뇌졸중
• 기타
• 정신질환
• 정신분열증
• 조울증
• 우울증
• 불안장애
• 기타
• 외상성 뇌손상(TBI)
• 뇌종양
• 기타

제7장 뇌영상 시장, 최종사용자별, 2020년-2032년

• 병원 및 진료소
• 진단센터
• 연구기관
• 외래수술센터(ASC)
• 기타

제8장 뇌영상 시장, 지역별, 2020년-2032년

• 북미
  • 미국
  • 캐나다
• 유럽
  • 독일
  • 영국
  • 스페인
  • 프랑스
  • 이탈리아
  • 러시아
  • 기타 유럽
• 아시아태평양
  • 중국
  • 인도
  • 일본
  • 호주
  • 한국
  • ASEAN
  • 기타 아시아태평양
• 라틴아메리카
  • 브라질
  • 아르헨티나
  • 멕시코
  • 기타 라틴아메리카
• 중동
  • GCC 국가
  • 이스라엘
  • 기타 중동
• 아프리카
  • 남아프리카
  • 북아프리카
  • 중앙아프리카

제9장 경쟁 구도

• 기업 개요
  • GE Healthcare
  • Siemens Healthineers
  • Philips Healthcare
  • Toshiba Medical Systems Corporation
  • Hitachi Healthcare
  • Canon Medical Systems Corporation
  • Mindray Medical International Limited
  • Esaote SpA
  • NeuroLogica Corporation
  • NeuroVive Pharmaceutical AG
  • Brainlab AG
  • Akili Interactive Labs Inc.
  • Brainomix Ltd.
  • Imaging Science International
  • Mevis Medical Solutions
  • NeuroVista
  • Neusoft Medical Systems
  • Positron Corporation
  • Shimadzu Corporation
  • Trifoil Imaging.

제10장 섹션

• 참고 문헌
• 조사 방법
• 출판사에 대해

영문목차

Neuroimaging Market is estimated to be valued at USD 42.28 Bn in 2025 and is expected to reach USD 63.57 Bn by 2032, growing at a compound annual growth rate (CAGR) of 6% from 2025 to 2032.

Neuroimaging is a branch of medical imaging that allows for the visualization of the structure and function of the brain. It provides valuable insights into the neurological processes and abnormalities that underline various diseases and disorders. This technology has revolutionized the field of neuroscience and has contributed significantly to understanding of the human brain.

Market Dynamics:

The neuroimaging market is driven by several factors. Growing prevalence of neurological disorders has increased the demand for accurate diagnostic tools, thus leading to the adoption of neuroimaging technologies. Moreover, the advancements in imaging technology, such as magnetic resonance imaging (MRI), positron emission tomography (PET), and computed tomography (CT), have significantly improved the resolution and accuracy of brain imaging.

However, the market also faces certain restraints. The high cost of neuroimaging equipment and the associated maintenance and operational costs limit its accessibility, especially in developing regions. Concerns regarding the safety of certain imaging modalities, such as ionizing radiation exposure in CT scans, pose challenges for market growth.

Nevertheless, the neuroimaging market presents several opportunities. The increasing investment in research and development (R&D) activities to develop advanced imaging techniques, such as functional magnetic resonance imaging (fMRI) and diffusion tensor imaging (DTI), is expected to drive market growth. Rising focus on personalized medicine and the integration of artificial intelligence (AI) in neuroimaging offer new avenues for market expansion.

Key features of the study:

• This report provides in-depth analysis of the neuroimaging market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period 2025-2032, considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the neuroimaging market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies. Key companies covered as a part of this study include General Electric Company, Siemens Healthineers AG, and Philips Healthcare, Toshiba Medical Systems Corporation, Hitachi Healthcare, Canon Medical Systems Corporation, Mindray Medical International Limited, Esaote SpA, NeuroLogica Corporation, NeuroVive Pharmaceutical AG, Brainlab AG, Akili Interactive Labs Inc., Brainomix Ltd., Imaging Science International, Mevis Medical Solutions, NeuroVista, Neusoft Medical Systems, Positron Corporation, Shimadzu Corporation, and Trifoil Imaging..
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The neuroimaging market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the neuroimaging market

Detailed Segmentation:

• Neuroimaging Market, By Technology:
  • Magnetic Resonance Imaging (MRI)
  • Computed Tomography (CT)
  • Positron Emission Tomography (PET)
  • Single Photon Emission Computed Tomography (SPECT)
  • Functional Magnetic Resonance Imaging (fMRI)
  • Diffusion Tensor Imaging (DTI)
  • Magnetoencephalography (MEG)
  • Electroencephalography (EEG)
  • Others
• Neuroimaging Market, By Application:
  • Neurological Disorders
  • Alzheimers Disease
  • Parkinsons Disease
  • Multiple Sclerosis
  • Epilepsy
  • Stroke
  • Others
  • Psychiatric Disorders
  • Schizophrenia
  • Bipolar Disorder
  • Depression
  • Anxiety Disorders
  • Others
  • Traumatic Brain Injury (TBI)
  • Brain Tumors
  • Others
• Neuroimaging Market, By End User:
  • Hospitals and Clinics
  • Diagnostic Centers
  • Research Institutes
  • Ambulatory Surgical Centers
  • Others
• Neuroimaging Market, By Region:
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa
• Company Profiles
  • GE Healthcare
  • Siemens Healthineers
  • Philips Healthcare
  • Toshiba Medical Systems Corporation
  • Hitachi Healthcare
  • Canon Medical Systems Corporation
  • Mindray Medical International Limited
  • Esaote SpA
  • NeuroLogica Corporation
  • NeuroVive Pharmaceutical AG
  • Brainlab AG
  • Akili Interactive Labs Inc.
  • Brainomix Ltd.
  • Imaging Science International
  • Mevis Medical Solutions
  • NeuroVista
  • Neusoft Medical Systems
  • Positron Corporation
  • Shimadzu Corporation
  • Trifoil Imaging

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Technology
  • Market Snippet, By Application
  • Market Snippet, By End User
  • Market Snippet, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Market Restraints
• Market Opportunities
• Key Highlights
• Regulatory Scenario
• Recent Trends
• Product Launches/Approvals
• PEST Analysis
• PORTERs Analysis
• Mergers, Acquisitions, and Collaborations

4. Neuroimaging Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Neuroimaging Market, By Technology, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Magnetic Resonance Imaging (MRI)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Computed Tomography (CT)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Positron Emission Tomography (PET)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Single Photon Emission Computed Tomography (SPECT)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Functional Magnetic Resonance Imaging (fMRI)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Diffusion Tensor Imaging (DTI)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Magnetoencephalography (MEG)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Electroencephalography (EEG)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

6. Neuroimaging Market, By Application, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Neurological Disorders
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Alzheimers Disease
• Parkinsons Disease
• Multiple Sclerosis
• Epilepsy
• Stroke
• Others
• Psychiatric Disorders
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Schizophrenia
• Bipolar Disorder
• Depression
• Anxiety Disorders
• Others
• Traumatic Brain Injury (TBI)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Brain Tumors
• Others

7. Neuroimaging Market, By End User, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2021 - 2032
  • Segment Trends
• Hospitals and Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Diagnostic Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Research Institutes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Ambulatory Surgical Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

8. Neuroimaging Market, By Region, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2021 -2032
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
    • U.S.
    • Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032, (US$ Bn)
    • South Africa
    • North Africa
    • Central Africa

9. Competitive Landscape

• Company Profile
  • GE Healthcare
• Company Highlights
• Product Portfolio
• Key Developments
• Financial Performance
• Strategies
  • Siemens Healthineers
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • Philips Healthcare
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • Toshiba Medical Systems Corporation
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • Hitachi Healthcare
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • Canon Medical Systems Corporation
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • Mindray Medical International Limited
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • Esaote SpA
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • NeuroLogica Corporation
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • NeuroVive Pharmaceutical AG
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • Brainlab AG
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • Akili Interactive Labs Inc.
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • Brainomix Ltd.
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • Imaging Science International
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • Mevis Medical Solutions
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • NeuroVista
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • Neusoft Medical Systems
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • Positron Corporation
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • Shimadzu Corporation
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • Trifoil Imaging.
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
• Analyst Views

10. Section

• References
• Research Methodology
• About us